Search Results - "van Imhoff, Gustaaf"

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial by Wulf, Gerald G., Altmann, Bettina, Ziepert, Marita, D’Amore, Francesco, Held, Gerhard, Greil, Richard, Tournilhac, Olivier, Relander, Thomas, Viardot, Andreas, Wilhelm, Martin, Wilhelm, Christian, Pezzutto, Antonio, Zijlstra, Josee M., Neste, Eric Van Den, Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Gelder, Michel van, van Imhoff, Gustaaf W., Zettl, Florian, Braulke, Friederike, Nickelsen, Maike, Glass, Bertram, Rosenwald, Andreas, Gaulard, Philippe, Loeffler, Markus, Pfreundschuh, Michael, Schmitz, Norbert, Trümper, Lorenz

“…PTCL patients exhibit poor survival with existing treatments. We investigated the efficacy of CHOP combined with alemtuzumab in 116 PTCL patients age 61–80 in…”
Get full text

Double-hit B-cell lymphomas by Aukema, Sietse M., Siebert, Reiner, Schuuring, Ed, van Imhoff, Gustaaf W., Kluin-Nelemans, Hanneke C., Boerma, Evert-Jan, Kluin, Philip M.

“…In many B-cell lymphomas, chromosomal translocations are biologic and diagnostic hallmarks of disease. An intriguing subset is formed by the so-called double-…”
Get full text

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study by van Imhoff, Gustaaf W, McMillan, Andrew, Matasar, Matthew J, Radford, John, Ardeshna, Kirit M, Kuliczkowski, Kazimierz, Kim, WonSeog, Hong, Xiaonan, Goerloev, Jette Soenderskov, Davies, Andrew, Barrigón, María Dolores Caballero, Ogura, Michinori, Leppä, Sirpa, Fennessy, Michael, Liao, Qiming, van der Holt, Bronno, Lisby, Steen, Hagenbeek, Anton

“…Purpose We compared the efficacy of ofatumumab (O) versus rituximab (R) in combination with cisplatin, cytarabine, and dexamethasone (DHAP) salvage treatment,…”
Get full text

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy? by Nijland, Marcel, Veenstra, Rianne N., Visser, Lydia, Xu, Chuanhui, Kushekhar, Kushi, van Imhoff, Gustaaf W., Kluin, Philip M., van den Berg, Anke, Diepstra, Arjan

“…Antigen presentation by tumor cells in the context of Human Leukocyte Antigen (HLA) is generally considered to be a prerequisite for effective immune…”
Get full text

Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin’s lymphoma by PLATTEL, Wouter J, DEN BERG, Anke Van, VISSER, Lydia, DER GRAAF, Anne-Marijn Van, PRUIM, Jan, VOS, Hans, HEPKEMA, Bouke, DIEPSTRA, Arjan, IMHOFF, Gustaaf W. Van

“…Plasma thymus and activation-regulated chemokine is a potential biomarker for classical Hodgkin's lymphoma. To define its value as a marker to monitor…”
Get full text

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma by Nijland, Marcel, Seitz, Annika, Terpstra, Martijn, van Imhoff, Gustaaf W, Kluin, Philip M, van Meerten, Tom, Atayar, Çiğdem, van Kempen, Léon C, Diepstra, Arjan, Kok, Klaas, van den Berg, Anke

“…Current genomic models in diffuse large B-cell lymphoma (DLBCL) are based on single tumor biopsies, which might underestimate heterogeneity. Data on mutational…”
Get full text

Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS by Kok, Laurence M. C., Bungener, Laura, de Bock, Geertruida H., Biswana, Anouschka, van der Wal, Geertiena, van Imhoff, Gustaaf W., Bellido, Mar

“…Moderate to severe chronic graft-versus-host disease (cGVHD) is associated with high morbidity, hospital dependency and poor quality of life. In this study, we…”
Get full text

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma by Zinzani, Pier Luigi, Karlin, Lionel, Radford, John, Caballero, Dolores, Fields, Paul, Chamuleau, Martine E D, d'Amore, Francesco, Haioun, Corinne, Thieblemont, Catherine, González-Barca, Eva, García, Carlos Grande, Johnson, Peter W, van Imhoff, Gustaaf W, Ng, Thomas, Dwyer, Karen, Morschhauser, Franck

Get full text

Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients by DIEPSTRA, Arjan, VAN IMHOFF, Gustaaf W, SCHAAPVELD, Michael, KARIM-KOS, Henrike, VAN DEN BERG, Anke, VELLENGA, Edo, POPPEMA, Sibrand

“…In classical Hodgkin's lymphoma (cHL), the impact of tumor cell Epstein-Barr virus (EBV) status on clinical outcome is controversial. We assessed failure-free…”
Get full text

Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren's Syndrome: A Retrospective Clinical Study by POLLARD, Rodney P. E, PIJPE, Justin, BOOTSMA, Hendrika, SPIJKERVET, Fred K. L, KLUIN, Philip M, ROODENBURG, Jan L. N, KALLENBERG, Cees G. M, VISSINK, Arjan, VAN IMHOFF, Gustaaf W

“…To retrospectively analyze the clinical course of patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma of the parotid gland and associated…”
Get full text

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial by Vellenga, Edo, van Putten, Wim L.J., van 't Veer, Mars B., Zijlstra, Josée M., Fibbe, Willem E., van Oers, Marinus H.J., Verdonck, Leo F., Wijermans, Pierre W., van Imhoff, Gustaaf W., Lugtenburg, Pieternella J., Huijgens, Peter C.

“…We evaluated the role of rituximab during remission induction chemotherapy in relapsed aggressive CD20+ non-Hodgkin lymphoma. Of 239 patients, 225 were…”
Get full text

Prognostic Impact of Germinal Center–Associated Proteins and Chromosomal Breakpoints in Poor-Risk Diffuse Large B-Cell Lymphoma by VAN IMHOFF, Gustaaf W, BOERMA, Evert-Jan G, VAN DER HOLT, Bronno, SCHUURING, Ed, VERDONCK, Leo F, KLUIN-NELEMANS, Hanneke C, KLUIN, Philip M

“…Outcome of diffuse large B-cell lymphoma (DLBCL) with a germinal center B-cell (GCB) expression profile is superior to that of non-GCB DLBCL. This conclusion…”
Get full text

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial by Chamuleau, Martine E D, Stenner, Frank, Chitu, Dana A, Novak, Urban, Minnema, Monique C, Geerts, Paul, Stevens, Wendy B C, Zenz, Thorsten, van Imhoff, Gustaaf W, Wu, Ka Lung, Demandt, Astrid M P, Kersten, Marie Jose, Terpstra, Wim E, Tick, Lidwine W, Deeren, Dries, Van Den Neste, Eric, Gregor, Michael, Veelken, Hendrik, Böhmer, Lara H, Caspar, Clemens B, Mutsaers, Pim, Refos, Jeannine M, Sewsaran, Robby, Fu, Liping, Seefat, Rianne L, Uyl-de Groot, Carin A, Dirnhofer, Stefan, Van Den Brand, Michiel, de Jong, Daphne, Nijland, Marcel, Lugtenburg, Pieternella

“…Patients with newly diagnosed high-risk Burkitt lymphoma are treated with high-intensity immune-chemotherapy regimens such as R-CODOX-M/R-IVAC or with…”
Get full text

Scrotal Irradiation in Primary Testicular Lymphoma: Review of the Literature and In Silico Planning Comparative Study by Brouwer, Charlotte L., MSc, Wiesendanger, Esther M., MD, van der Hulst, Peter C., MSc, van Imhoff, Gustaaf W., MD, PhD, Langendijk, Johannes A., MD, PhD, Beijert, Max, MD

“…We examined adjuvant irradiation of the scrotum in primary testicular lymphoma (PTL) by means of a literature review in MEDLINE, a telephone survey among Dutch…”
Get full text

Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups by Urayama, Kevin Y., Jarrett, Ruth F., Hjalgrim, Henrik, Diepstra, Arjan, Kamatani, Yoichiro, Chabrier, Amelie, Gaborieau, Valerie, Boland, Anne, Nieters, Alexandra, Becker, Nikolaus, Foretova, Lenka, Benavente, Yolanda, Maynadié, Marc, Staines, Anthony, Shield, Lesley, Lake, Annette, Montgomery, Dorothy, Taylor, Malcolm, Smedby, Karin Ekström, Amini, Rose-Marie, Adami, Hans-Olov, Glimelius, Bengt, Feenstra, Bjarke, Nolte, Ilja M., Visser, Lydia, van Imhoff, Gustaaf W., Lightfoot, Tracy, Cocco, Pierluigi, Kiemeney, Lambertus, Vermeulen, Sita H., Holcatova, Ivana, Vatten, Lars, Macfarlane, Gary J., Thomson, Peter, Conway, David I., Benhamou, Simone, Agudo, Antonio, Healy, Claire M., Overvad, Kim, Tjønneland, Anne, Melin, Beatrice, Canzian, Federico, Khaw, Kay-Tee, Travis, Ruth C., Peeters, Petra H. M., González, Carlos A., Quirós, José Ramón, Sánchez, María-José, Huerta, José María, Ardanaz, Eva, Dorronsoro, Miren, Clavel-Chapelon, Françoise, Bueno-de-Mesquita, H. Bas, Riboli, Elio, Roman, Eve, Boffetta, Paolo, de Sanjosé, Silvia, Zelenika, Diana, Melbye, Mads, van den Berg, Anke, Lathrop, Mark, Brennan, Paul, McKay, James D.

“…Background Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein-Barr virus (EBV) status. This…”
Get full text

HLA Class II Expression by Hodgkin Reed-Sternberg Cells Is an Independent Prognostic Factor in Classical Hodgkin's Lymphoma by DIEPSTRA, Arjan, VAN IMHOFF, Gustaaf W, POPPEMA, Sibrand, KARIM-KOS, Henrike E, VAN DEN BERG, Anke, TE MEERMAN, Gerard J, NIENS, Marijke, NOLTE, Ilja M, BASTIAANNET, Esther, SCHAAPVELD, Michael, VELLENGA, Edo

“…The neoplastic Hodgkin Reed-Sternberg (HRS) cells in classical Hodgkin's lymphoma (cHL) are derived from B cells. The frequency of HLA class II downregulation…”
Get full text

Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin’s lymphoma by Xu, Chuanhui, Plattel, Wouter, van den Berg, Anke, Rüther, Nele, Huang, Xin, Wang, Miao, de Jong, Debora, Vos, Hans, van Imhoff, Gustaaf, Viardot, Andreas, Möller, Peter, Poppema, Sibrand, Diepstra, Arjan, Visser, Lydia

“…The c-Met signaling pathway regulates a variety of biological processes, including proliferation, survival and migration. Deregulated c-Met activation has been…”
Get full text

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis by Schuurmans, Mascha, Bromberg, Jacoline E. C., Doorduijn, Jeanette, Poortmans, Philip, Taphoorn, Martin J. B., Seute, Tatjana, Enting, Roelien, Van Imhoff, Gustaaf, Van Norden, Yvette, Van Den Bent, Martin J.

“…Summary Elderly patients with primary central nervous ystem lymphoma (PCNSL) do not tolerate treatment with combined radio‐chemotherapy well because of…”
Get full text

Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation by Bakker, Nicolaas A, van Imhoff, Gustaaf W, Verschuuren, Erik A M, van Son, Willem J

“…Post-transplant lymphoproliferative disorder (PTLD) is a serious and still frequently observed complication of solid organ transplantation. Despite the recent…”
Get more information

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma by Schaapveld, Michael, Aleman, Berthe M.P, van Eggermond, Anna M, Janus, Cécile P.M, Krol, Augustinus D.G, van der Maazen, Richard W.M, Roesink, Judith, Raemaekers, John M.M, de Boer, Jan Paul, Zijlstra, Josée M, van Imhoff, Gustaaf W, Petersen, Eefke J, Poortmans, Philip M.P, Beijert, Max, Lybeert, Marnix L, Mulder, Ina, Visser, Otto, Louwman, Marieke W.J, Krul, Inge M, Lugtenburg, Pieternella J, van Leeuwen, Flora E

“…Despite efforts to reduce the incidence of second cancer, the risk was not lower among 5-year survivors of Hodgkin's lymphoma in the Netherlands treated…”
Get full text